Vertical Venture Partners
VC Fund
Menlo Park, United States
Vertical Venture Partners ("VVP") is a venture capital firm investing in enterprise technology companies that target specific vertical markets. VVP focuses on companies with solutions for pain points that are C-suite priorities. Some vertical markets of interest include: Aerospace and Defense, Energy, Financial Services, Healthcare, Insurance, Real Estate, Retail, and Transportation. Some technology areas of interest include: Business Intelligence, Cloud Applications, CRM, Mobile, Security, Software Infrastructure, Instrumentation and Materials Science.
- Total investments:
- 79
- Last investment:
- Lead investor:
- 39%
- Fund size:
- $60M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Vertical Venture Partners invests in
Stages Vertical Venture Partners invests in
Countries Vertical Venture Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $500k–$8M
- Series A
- $6M–$24M
- Series B
- $10M–$75M
Investment Focus
Industry
- Software 16 (20%)
- Health Care 14 (18%)
- Biotechnology 11 (14%)
- Artificial Intelligence 11 (14%)
- SaaS 6 (8%)
Stage
- Series A 28 (35%)
- Seed 17 (22%)
- Series B 14 (18%)
- Series C 3 (4%)
- Funding Round 3 (4%)
Country
- United States 42 (53%)
- United Kingdom 2 (3%)
- Spain 1 (1%)
- Ireland 1 (1%)
- Colombia 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brad Corona
Managing Director
|
Managing Director | Total investments: 6 | Find email | |
David Schwab
Founder & Managing Director
|
Founder & Managing Director | Total investments: 24 | Find email | |
|
Matthew Schwab
Associate
|
Associate | Total investments: 0 | Find email | |
Paul Conley
Managing Director
|
Managing Director | Total investments: 25 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Mongoose Software unlocks the next era of healthcare innovation, and it gives product and experience teams the freedom to create without engineering bottlenecks. | Seed / May 13, 2026 | ||
| Surf Therapeutics is a clinical-stage firm leading the development of non-invasive ultrasound neuromodulation technology to modify immune-related pathways. | $6M / Seed / Mar 17, 2026 | ||
| Planet Smart is a London-based deep tech startup creating smarter biomaterials for a better planet. Its flagship innovation, PlanetSorb™, is the world’s first naturally biodegradable, high-performance superabsorbent polymer designed to replace fossil-based plastics in hygiene, agriculture, packaging and mining waste products. Founded by Dr GeraldMarin and Maurice Rüttimann, Planet Smart’s mission is to eliminate microplastics from everyday life and prove that sustainable design can outperform the status quo. | $1M / Pre-Seed / Nov 18, 2025 | ||
| Hermes Biosciences describes a benchtop, hands-off extracellular vesicle isolation system designed to purify exosomes quickly, efficiently, and reproducibly from any bodily fluid or cell culture media. This technology aims to advance research into exosome function and support clinical applications in oncology, degenerative disease, and regenerativemedicine. | $6M / Seed / Nov 18, 2025 | ||
| Reinvigorating neighborhoods by supporting real estate entrepreneurs with innovative technology and capital. | $10M / Nov 14, 2025 | ||
| Mongoose Software unlocks the next era of healthcare innovation, and it gives product and experience teams the freedom to create without engineering bottlenecks. | Seed / Sep 17, 2025 | ||
| Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $20M / Sep 15, 2025 | ||
| Barti offers an AI-powered electronic health record and practice management platform tailored for eye care providers. The company delivers tools that streamline eye exam documentation through AI Scribe, simplify patient intake, scheduling, billing, messaging, and optical/contact lens ordering, unifying practice operations under a singlesystem. It incorporates AI-driven capabilities like AI History and AI Smart Scan to expedite information retrieval and data entry from documents. Designed in collaboration with optometrists, ophthalmologists, and opticians, the platform addresses specialty needs through features such as myopia management and vision therapy templates.Barti was founded in 2021 and is headquartered in San Francisco, USA. | $12M / Series A / Aug 25, 2025 | ||
| Domos' AI, augments a human to which property managers delegate tasks to. Domos' assistant can communicate via email, voice, and chat, connect to every internal system, and takes on the most manual, inconsistent and time-consuming tasks to improve operational efficiency and resident satisfaction. | $3.3M / Seed / Apr 28, 2025 | ||
| HeyLibby is the AI sales assistant and best kept secret for small business owners to engage, qualify, and convert leads. | $4.5M / Seed / Apr 03, 2025 | ||
| See all 79 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Vertical Venture Partners invest in?
Vertical Venture Partners invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 79 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Vertical Venture Partners invest in?
Vertical Venture Partners typically joins rounds of $500k–$8M at Seed, $6M–$24M at Series A and $10M–$75M at Series B. These are whole funding-round sizes, not Vertical Venture Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Vertical Venture Partners took part in.
How do I contact Vertical Venture Partners?
Public channels for Vertical Venture Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Vertical Venture Partners?
The team at Vertical Venture Partners includes Brad Corona (Managing Director), David Schwab (Founder & Managing Director) and Matthew Schwab (Associate). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
